Literature DB >> 30084265

An overview of meningiomas.

Robin A Buerki1, Craig M Horbinski2,3, Timothy Kruser3,4, Peleg M Horowitz5, Charles David James3,6, Rimas V Lukas3,7.   

Abstract

Meningiomas are the most common primary intracranial tumor. Important advances are occurring in meningioma research. These are expected to accelerate, potentially leading to impactful changes on the management of meningiomas in the near and medium term. This review will cover the histo- and molecular pathology of meningiomas, including recent 2016 updates to the WHO classification of CNS tumors. We will discuss clinical and radiographic presentation and therapeutic management. Surgery and radiotherapy, the two longstanding primary therapeutic modalities, will be discussed at length. In addition, data from prior and ongoing investigations of other treatment modalities, including systemic and targeted therapies, will be covered. This review will quickly update the reader on the contemporary management and future directions in meningiomas. [Formula: see text].

Entities:  

Keywords:  chemotherapy; imaging; meningioma; molecular pathology; mutations; radiotherapy; stereotactic radiosurgery; surgery; targeted therapy; tumor treating fields

Mesh:

Year:  2018        PMID: 30084265      PMCID: PMC6123887          DOI: 10.2217/fon-2018-0006

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  80 in total

1.  Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen.

Authors:  Joshua R Menke; David R Raleigh; Allen M Gown; Sean Thomas; Arie Perry; Tarik Tihan
Journal:  Acta Neuropathol       Date:  2015-07-21       Impact factor: 17.088

2.  Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue.

Authors:  Walter Rachinger; Veit M Stoecklein; Nicole A Terpolilli; Alexander R Haug; Lorenz Ertl; Julia Pöschl; Ulrich Schüller; Christian Schichor; Niklas Thon; Jörg-Christian Tonn
Journal:  J Nucl Med       Date:  2015-01-29       Impact factor: 10.057

3.  Stereotactic LINAC radiosurgery for incompletely resected or recurrent atypical and anaplastic meningiomas.

Authors:  Mustapha El-Khatib; Faycal El Majdoub; Mauritius Hoevels; Martin Kocher; Rolf-Peter Müller; Hans-Jakob Steiger; Volker Sturm; Mohammad Maarouf
Journal:  Acta Neurochir (Wien)       Date:  2011-06-25       Impact factor: 2.216

Review 4.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

5.  Progesterone and estrogen receptors in meningiomas: prognostic considerations.

Authors:  D W Hsu; J T Efird; E T Hedley-Whyte
Journal:  J Neurosurg       Date:  1997-01       Impact factor: 5.115

6.  Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.

Authors:  Manish K Aghi; Bob S Carter; Garth R Cosgrove; Robert G Ojemann; Sepideh Amin-Hanjani; Robert L Martuza; William T Curry; Fred G Barker
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

7.  IFN-α for recurrent surgery- and radiation-refractory high-grade meningioma: a retrospective case series.

Authors:  Marc C Chamberlain
Journal:  CNS Oncol       Date:  2013-05

8.  The role of radiotherapy following gross-total resection of atypical meningiomas.

Authors:  Ricardo J Komotar; J Bryan Iorgulescu; Daniel M S Raper; Eric C Holland; Kathryn Beal; Mark H Bilsky; Cameron W Brennan; Viviane Tabar; Jonathan H Sherman; Yoshiya Yamada; Philip H Gutin
Journal:  J Neurosurg       Date:  2012-08-24       Impact factor: 5.115

9.  TERT Promoter Mutations and Risk of Recurrence in Meningioma.

Authors:  Felix Sahm; Daniel Schrimpf; Adriana Olar; Christian Koelsche; David Reuss; Juliane Bissel; Annekathrin Kratz; David Capper; Sebastian Schefzyk; Thomas Hielscher; Qianghu Wang; Erik P Sulman; Sebastian Adeberg; Arend Koch; Ali Fuat Okuducu; Stefanie Brehmer; Jens Schittenhelm; Albert Becker; Benjamin Brokinkel; Melissa Schmidt; Theresa Ull; Konstantinos Gousias; Almuth Friederike Kessler; Katrin Lamszus; Jürgen Debus; Christian Mawrin; Yoo-Jin Kim; Matthias Simon; Ralf Ketter; Werner Paulus; Kenneth D Aldape; Christel Herold-Mende; Andreas von Deimling
Journal:  J Natl Cancer Inst       Date:  2015-12-13       Impact factor: 13.506

10.  Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.

Authors:  Leland Rogers; Peixin Zhang; Michael A Vogelbaum; Arie Perry; Lynn S Ashby; Jignesh M Modi; Anthony M Alleman; James Galvin; David Brachman; Joseph M Jenrette; John De Groot; Joseph A Bovi; Maria Werner-Wasik; Jonathan P S Knisely; Minesh P Mehta
Journal:  J Neurosurg       Date:  2017-10-06       Impact factor: 5.115

View more
  76 in total

1.  Giant posterior fossa meningioma: the importance of early diagnosis and challenges concerning treatment.

Authors:  Cristiano Antunes; Rui Ramos; Maria João Machado; Miguel Afonso Filipe
Journal:  BMJ Case Rep       Date:  2019-03-20

2.  Differentiating microcystic meningioma from atypical meningioma using diffusion-weighted imaging.

Authors:  Ke Xiaoai; Zhou Qing; Han Lei; Zhou Junlin
Journal:  Neuroradiology       Date:  2020-01-29       Impact factor: 2.804

Review 3.  Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.

Authors:  Ansley Unterberger; Thien Nguyen; Courtney Duong; Aditya Kondajji; Daniel Kulinich; Isaac Yang
Journal:  J Neurooncol       Date:  2021-02-26       Impact factor: 4.130

4.  Trends in the Management Paradigms of Intracranial Meningioma.

Authors:  Zaid Aljuboori; Ahmad Alhourani; Shiao Woo; Eyas Hattab; Mehran Yusuf; Megan Nelson; Norberto Andaluz; Dale Ding; Jesse Savage; Brian Williams
Journal:  J Neurol Surg B Skull Base       Date:  2019-09-17

Review 5.  Clinical neuro-oncology for the neurologist.

Authors:  Rimas V Lukas; Jennie W Taylor; Sylvia C Kurz; Nimish A Mohile
Journal:  Neurol Clin Pract       Date:  2020-10

6.  Intraventricular meningioma admixed with choroid plexus papilloma: a rare case report with review of literature.

Authors:  So-Woon Kim; Jiwook Ryu; Kiyong Na
Journal:  Int J Clin Exp Pathol       Date:  2021-04-15

7.  Racial and socioeconomic correlates of treatment and survival among patients with meningioma: a population-based study.

Authors:  Hriday P Bhambhvani; Adrian J Rodrigues; Zachary A Medress; Melanie Hayden Gephart
Journal:  J Neurooncol       Date:  2020-03-19       Impact factor: 4.130

8.  Utility of multiparametric pre-operative magnetic resonance imaging in differentiation of chordoid meningioma from the other histopathological subtypes of meningioma-a retrospective study.

Authors:  Sameer Peer; Jitender Saini; Chandrajit Prasad; Karthik Kulanthaivelu; Nishanth Sadashiva; Bevinahalli N Nandeesh; Alok Mohan Uppar; Shilpa Rao
Journal:  Neuroradiology       Date:  2021-04-10       Impact factor: 2.804

Review 9.  Current experimental therapies for atypical and malignant meningiomas.

Authors:  Andres M Corona; Long Di; Ashish H Shah; Raphael Crespo; Daniel G Eichberg; Victor M Lu; Evan M Luther; Ricardo J Komotar; Michael E Ivan
Journal:  J Neurooncol       Date:  2021-05-05       Impact factor: 4.130

10.  Surgical Management of Giant Intracranial Meningiomas.

Authors:  Soner Yaşar; Alparslan Kırık
Journal:  Eurasian J Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.